Delisted from NASDAQ in Aug 2023
PTE - PolarityTE, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
Salt Lake City,
United States
Type: Equity
PTE price evolution
PTE
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.39 | $11.45 | $16.09 | $20.52 |
| Short term investments | ||||
| Net receivables | $0.45 | $0.33 | $0.1 | $0.1 |
| Inventory | ||||
| Total current assets | $8.93 | $13.26 | $18.49 | $22.9 |
| Long term investments | ||||
| Property, plant & equipment | $8.21 | $8.68 | $2.75 | $4.22 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $9.12 | $9.59 | $3.66 | $5.13 |
| Total investments | ||||
| Total assets | $18.05 | $22.85 | $22.14 | $28.03 |
| Current liabilities | ||||
| Accounts payable | $1.71 | $0.46 | $1.9 | $1.94 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $2.17 | $2.07 | $2.8 | $3.51 |
| Long term debt | $2.5 | $0.04 | $0.05 | $0.06 |
| Total noncurrent liabilities | $3.46 | $4.16 | $2.4 | $4.47 |
| Total debt | $2.5 | $2.67 | $0.05 | $0.06 |
| Total liabilities | $5.63 | $6.23 | $5.2 | $7.99 |
| Shareholders' equity | ||||
| Retained earnings | -$520.47 | -$516.23 | -$515.64 | -$512.24 |
| Other shareholder equity | ||||
| Total shareholder equity | $12.42 | $16.62 | $16.94 | $20.05 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $11.45 | $19.38 | $25.52 | $10.22 |
| Short term investments | $19.02 | |||
| Net receivables | $0.33 | $0.98 | $3.82 | $1.73 |
| Inventory | $0.88 | $0.25 | ||
| Total current assets | $13.26 | $22.39 | $31.22 | $32.49 |
| Long term investments | ||||
| Property, plant & equipment | $8.68 | $8.07 | $13 | $19.5 |
| Goodwill & intangible assets | $0.82 | $1.01 | ||
| Total noncurrent assets | $9.59 | $8.79 | $14.29 | $21.11 |
| Total investments | $19.02 | |||
| Total assets | $22.85 | $31.18 | $45.51 | $53.6 |
| Current liabilities | ||||
| Accounts payable | $0.46 | $3.12 | $4.15 | $7.09 |
| Deferred revenue | $0.07 | $0.17 | $0.1 | |
| Short long term debt | $2.06 | $0.53 | ||
| Total current liabilities | $2.07 | $4.71 | $8.48 | $10.06 |
| Long term debt | $0.04 | $0.04 | $2.99 | $2.99 |
| Total noncurrent liabilities | $4.16 | $7.22 | $9.69 | $4.62 |
| Total debt | $2.67 | $0.04 | $5.05 | $3.52 |
| Total liabilities | $6.23 | $11.93 | $18.17 | $14.68 |
| Shareholders' equity | ||||
| Retained earnings | -$516.23 | -$508.4 | -$478.21 | -$435.36 |
| Other shareholder equity | $0.07 | |||
| Total shareholder equity | $16.62 | $19.24 | $27.34 | $38.92 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.07 | |||
| Cost of revenue | $0.13 | |||
| Gross Profit | -$0.05 | |||
| Operating activities | ||||
| Research & development | $2.28 | $2.56 | $2.55 | $3.08 |
| Selling, general & administrative | $2.46 | $2.57 | $2.69 | $3.56 |
| Total operating expenses | $4.8 | $1.36 | $5.41 | $6.68 |
| Operating income | -$4.8 | -$1.36 | -$5.41 | -$6.73 |
| Income from continuing operations | ||||
| EBIT | -$4.27 | -$0.62 | -$3.4 | -$0.05 |
| Income tax expense | ||||
| Interest expense | -$0.03 | -$0.02 | $0 | $0.01 |
| Net income | ||||
| Net income | -$4.24 | -$0.59 | -$3.4 | -$0.07 |
| Income (for common shares) | -$4.24 | -$0.59 | -$3.4 | -$0.07 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.81 | $9.4 | $10.13 | $5.65 |
| Cost of revenue | $0.62 | $4.32 | $4.42 | $2.48 |
| Gross Profit | $0.2 | $5.09 | $5.7 | $3.17 |
| Operating activities | ||||
| Research & development | $11.05 | $14.18 | $11.53 | $16.4 |
| Selling, general & administrative | $15.03 | $23.28 | $36.28 | $80.17 |
| Total operating expenses | $22.57 | $38.77 | $51.64 | $96.57 |
| Operating income | -$22.37 | -$33.69 | -$45.94 | -$93.39 |
| Income from continuing operations | ||||
| EBIT | -$7.82 | -$30.06 | -$42.67 | -$92.49 |
| Income tax expense | ||||
| Interest expense | $0.01 | $0.13 | $0.18 | |
| Net income | ||||
| Net income | -$7.83 | -$30.19 | -$42.85 | -$92.49 |
| Income (for common shares) | -$7.83 | -$30.19 | -$42.85 | -$92.49 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$4.24 | -$0.59 | -$3.4 | -$0.07 |
| Operating activities | ||||
| Depreciation | $0.15 | $0.28 | $0.37 | $0.4 |
| Business acquisitions & disposals | $2.33 | |||
| Stock-based compensation | $0.05 | $0.27 | $0.3 | $0.53 |
| Total cash flows from operations | -$5.08 | -$4.3 | -$4.03 | -$8.23 |
| Investing activities | ||||
| Capital expenditures | $0.1 | $0.06 | $0.02 | $0.16 |
| Investments | ||||
| Total cash flows from investing | $0.1 | $0.06 | $0.02 | $2.48 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | $7.83 | ||
| Net borrowings | -$0.07 | -$0.09 | -$0.42 | -$0.41 |
| Total cash flows from financing | -$0.07 | -$0.41 | -$0.42 | $7.36 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$5.05 | -$4.65 | -$4.42 | $1.62 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$7.83 | -$30.19 | -$42.85 | -$92.49 |
| Operating activities | ||||
| Depreciation | $1.51 | $2.84 | $3.26 | $3.19 |
| Business acquisitions & disposals | $2.33 | |||
| Stock-based compensation | $1.86 | $5.38 | $7.26 | $31.4 |
| Total cash flows from operations | -$22.6 | -$22.63 | -$37.75 | -$56.65 |
| Investing activities | ||||
| Capital expenditures | $0.22 | -$0.1 | -$1.34 | -$2.77 |
| Investments | $18.97 | -$12.84 | ||
| Total cash flows from investing | $2.54 | -$0.1 | $17.63 | -$15.62 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.83 | $16.61 | $33.13 | $28.7 |
| Net borrowings | -$0.01 | -$0.58 | $2.45 | -$0.99 |
| Total cash flows from financing | $12.13 | $16.58 | $35.42 | $26.81 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$7.93 | -$6.15 | $15.3 | -$45.45 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 7.33M |
| Revenue | $73.00K |
|---|---|
| EBITDA | -$7.14M |
| EBIT | -$8.34M |
| Net Income | -$8.30M |
| Revenue Q/Q | -100.00% |
| Revenue Y/Y | -98.66% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 1.70 |
| Cash/Share | 0.87 |
| EPS | -$1.13 |
|---|---|
| ROA | -36.48% |
| ROE | -50.31% |
| Debt/Equity | 0.37 |
|---|---|
| Net debt/EBITDA | 0.11 |
| Current ratio | 4.11 |
| Quick ratio | 4.11 |